These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9379445

  • 1. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.
    Paterlini G, Portoghese PS, Ferguson DM.
    J Med Chem; 1997 Sep 26; 40(20):3254-62. PubMed ID: 9379445
    [Abstract] [Full Text] [Related]

  • 2. Building 3D-structural model of kappa opioid receptor and studying its interaction mechanism with dynorphin A(1-8).
    Wan XH, Huang XQ, Zhou DH, Jiang HL, Chen KX, Chi ZQ.
    Acta Pharmacol Sin; 2000 Aug 26; 21(8):701-8. PubMed ID: 11501178
    [Abstract] [Full Text] [Related]

  • 3. NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles.
    Tessmer MR, Kallick DA.
    Biochemistry; 1997 Feb 25; 36(8):1971-81. PubMed ID: 9047294
    [Abstract] [Full Text] [Related]

  • 4. Prediction of the conformational requirements for binding to the kappa-opioid receptor and its subtypes. I. Novel alpha-helical cyclic peptides and their role in receptor selectivity.
    Collins N, Hruby VJ.
    Biopolymers; 1994 Sep 25; 34(9):1231-41. PubMed ID: 7948735
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B, Meng F, Akil H.
    Neurobiol Dis; 1996 Feb 25; 3(1):87-96. PubMed ID: 9173916
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS, Zheng MQ, Murray TF, Aldrich JV.
    J Med Chem; 2003 Sep 11; 46(19):4002-8. PubMed ID: 12954053
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor.
    Przydzial MJ, Pogozheva ID, Bosse KE, Andrews SM, Tharp TA, Traynor JR, Mosberg HI.
    J Pept Res; 2005 Mar 11; 65(3):333-42. PubMed ID: 15787963
    [Abstract] [Full Text] [Related]

  • 13. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family.
    Zhang S, Tong Y, Tian M, Dehaven RN, Cortesburgos L, Mansson E, Simonin F, Kieffer B, Yu L.
    J Pharmacol Exp Ther; 1998 Jul 11; 286(1):136-41. PubMed ID: 9655852
    [Abstract] [Full Text] [Related]

  • 14. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors.
    Gouldson PR, Snell CR, Reynolds CA.
    J Med Chem; 1997 Nov 21; 40(24):3871-86. PubMed ID: 9397168
    [Abstract] [Full Text] [Related]

  • 15. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.
    Xue JC, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L, Liu-Chen LY.
    J Biol Chem; 1994 Dec 02; 269(48):30195-9. PubMed ID: 7982926
    [Abstract] [Full Text] [Related]

  • 16. NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor.
    O'Connor C, White KL, Doncescu N, Didenko T, Roth BL, Czaplicki G, Stevens RC, Wüthrich K, Milon A.
    Proc Natl Acad Sci U S A; 2015 Sep 22; 112(38):11852-7. PubMed ID: 26372966
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU, Bembenek SD, Szalma S.
    J Mol Graph Model; 2006 May 22; 24(6):456-64. PubMed ID: 16386444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF, Xu H, Liu-Chen LY, Chen C, Partilla JS, Brine GA, Carroll FI, Rice KC, Lai J, Porreca F, Sadee W, Rothman RB.
    Synapse; 1998 Feb 22; 28(2):117-24. PubMed ID: 9450512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.